6 completed, 2 recruiting, 1 not yet recruiting, 1 terminated. 11 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 11 | Completed 6, Recruiting 2, Not yet recruiting 1, Terminated 1, Unknown 1 |
Follow Embolism: new trials by email Literature Review of Embolism trials Research Report on Embolism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mechanical Thrombectomy for Acute Pulmonary Embolism Innovative Device Group, Standard Pharmacological Therapy Group - Acute Pulmonary Embolism | Early Phase 1 | Not yet recruiting | RenJi Hospital | 200 | 2025-07-01 | 2025-06-22 |
| Apixaban in Thrombocytopenia Apixaban - Deep Vein Thrombosis, Pulmonary Embolism and Thrombosis | Early Phase 1 | Recruiting | Rushad Patell | 30 | 2025-02-28 | 2026-04-15 |
| Supplemental Oxygen in Pulmonary Embolism (SO-PE) Oxygen Therapy, Non-rebreather mask - Pulmonary Embolism, Venous Thromboembolism | Early Phase 1 | Recruiting | Massachusetts General Hospital | 80 | 2023-10-01 | 2025-06-15 |
| Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease Apixaban 2.5 milligram, Placebo Oral Tablet - IBD, Venous Thromboembolism | Early Phase 1 | Unknown | McMaster University | 60 | 2021-09-01 | 2024-01-05 |
| Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders HP 3He, HP 129Xe, PFP - Lung Transplant, Lung Resection | Early Phase 1 | Terminated | Thunder Bay Regional Health Research Institute | 10 | 2020-11-10 | 2024-10-15 |
| Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity Aspirin 81 mg, Placebo - Venous Thromboembolism, Postpartum Period | Early Phase 1 | Completed | University of Calgary | 257 | 2020-10-07 | 2023-09-13 |
| Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin Standard heparin dose, Real time heparin dose adjustment - Deep Vein Thrombosis, Pulmonary Embolism | Early Phase 1 | Completed | University of Utah | 20 | 2018-03-23 | 2023-05-17 |
| Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin Real time heparin dose adjustment, Standard heparin dose - Deep-Venous Thrombosis, Pulmonary Embolism | Early Phase 1 | Completed | University of Utah | 20 | 2016-11-10 | 2019-07-24 |
| Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose Real time enoxaparin dose adjustment, Standard enoxaparin dose - Deep Venous Thrombosis, Pulmonary Embolus | Early Phase 1 | Completed | University of Utah | 116 | 2016-03-01 | 2019-05-24 |
| Sildenafil in Acute Pulmonary Embolism Sildenafil, Placebo - Pulmonary Embolism | Early Phase 1 | Completed | University of Aarhus | 20 | 2015-03-01 | 2020-02-25 |
| Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients Enoxaparin, Fondaparinux - Deep Venous Thrombosis, Pulmonary Embolism | Early Phase 1 | Completed | Johns Hopkins University | 198 | 2009-06-01 | 2019-06-07 |
Pulmonary Embolism (11) · Venous Thromboembolism (7) · Venous Thrombosis (6) · Asbestosis (1) · Asthma (1) · Bronchiectasis (1) · Colitis, Ulcerative (1) · Crohn Disease (1) · Cystic Fibrosis (1) · Emphysema (1) · Hypertension, Pulmonary (1) · Lung Diseases, Interstitial (1) · Lung Neoplasms (1) · Mesothelioma (1) · Postpartum Hemorrhage (1)
Cardiovascular Diseases (11) · Embolism and Thrombosis (11) · Lung Diseases (11) · Respiratory Tract Diseases (11) · Vascular Diseases (11) · Thromboembolism (6) · Thrombosis (5) · Digestive System Diseases (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Adenoma (1) · Apnea (1)
Aspirin (1) · Enoxaparin (1) · Fondaparinux (1) · Oxygen (1) · Sildenafil Citrate (1) · Sulfur Hexafluoride (1) · apixaban (1) · perflutren (1)
University of Utah (3) · Johns Hopkins University (1) · Massachusetts General Hospital (1) · McMaster University (1) · RenJi Hospital (1) · Rushad Patell (1) · Thunder Bay Regional Health Research Institute (1) · University of Aarhus (1) · University of Calgary (1)
United States (6) · Canada (3) · Denmark (1) · France (1) · Ireland (1) · Netherlands (1)
Anne Prazak, PharmD (1) · Asger Andersen, MD,PhD (1) · Christopher Kabrhel, MD, MPH (1) · Christopher Puccini, MD (1) · Corinne Bertolaccini, PharmD (1) · Kimberley E Steele, MD (1) · Leslie Skeith, MD (1) · Marc Rodger, MD (1) · Mitchell S Albert, PhD (1) · Rushad Patell, MD (1)
PMID 31116389, PMID 33086312, PMID 33639897, PMID 33779986, PMID 35584850, PMID 35762891, PMID 36413425, PMID 39238110, PMID 39532350, PMID 39827892, PMID 41821307, PMID 42056311